Evidence map›Paper›PMID 41313550›Full record

ArticleAdvances in therapy2026

Correction to: Epidemiology Landscape and Impact of Overweight and Obesity in Adults: Multi-country Results from the IMPACT-O Study.

Esther Artime, Erik Spaepen, Sarah Zimner-Rapuch, Anastasia Lampropoulou, Atif Adam, Xiaoyu Lin, Mengyuan Shang, Sarah Seager, Carel W Le Roux, Dror Dicker

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Esther ArtimeEli Lilly and Company, Indianapolis, IN, USA. artime_esther@lilly.com.
Erik SpaepenHaaPACS GmbH, Schriesheim, Germany.
Sarah Zimner-RapuchEli Lilly and Company, Indianapolis, IN, USA.
Anastasia LampropoulouEli Lilly and Company, Indianapolis, IN, USA.
Atif AdamIQVIA Inc., London, UK.
Xiaoyu LinIQVIA Inc., London, UK.
Mengyuan ShangIQVIA Inc., London, UK.
Sarah SeagerIQVIA Inc., London, UK.
Carel W Le RouxDiabetes Complications Research Centre, Conway Institute, University College Dublin, Dublin, Ireland.
Dror DickerDepartment of Medicine and Obesity Clinic, Rabin Medical Center (HaSharon Hospital), Petah Tikva, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41313550
PMCPMC12858546

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.